Back to Lagevrio (Eua) Prices

Lagevrio (Eua)

Molnupiravir

What is Lagevrio (Eua) used for?

Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. It is used by adults 18 years of age and older who have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.

CHEMICAL NAME

Molnupiravir

DRUG TYPE

Viral Infections
InsideRx Coupon Icon

Get Lagevrio (Eua) Savings

Compare prices for Lagevrio (Eua) and save up to 80%.

The Savings Card works just like a coupon!

What does Lagevrio (Eua) look like?

View more images (1)

Lagevrio (Eua) Frequently Asked Questions

Take this medication by mouth with or without food as directed by your doctor, usually every morning and evening, 12 hours apart, for 5 days. Swallow the capsules whole. Do not open, break, or crush the capsules. Let your doctor know if you cannot swallow the capsules whole. The dosage is based on your medical condition and response to treatment.

If you are giving this medication through a tube into the stomach (nasogastric or orogastric tube), consult the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use or your health care professional for detailed instructions on how to properly give it.

Continue to take this medication for the full time prescribed, even if symptoms disappear after a few days. Stopping the medication too early may result in a return of the infection or failure to protect you from the virus.

Tell your doctor if your condition lasts or gets worse.

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Lagevrio (Eua) Dosage and Form Information

Capsule
200 Mg